Frank J.
- Country
- Germany
- Department
- II. Med. Klinik
Research Overview
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- Evaluation of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab in HER2-Positive Biliary Tract Cancer: A Phase II Clinical Trial
- Phase II Evaluation of Durvalumab and Tremelimumab with Y-90 SIRT in Advanced Intrahepatic Biliary Tract Cancer
Data & Insights
Has run more than one trial at 52 of 240 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced biliary tract cancers and metastatic colorectal cancer, with particular focus on innovative therapeutic approaches.
- Intrahepatic biliary tract cancer management
- Colorectal cancer metastasis treatment
- HER2-positive biliary tract cancers
Expertise extends to targeted and immunotherapy combinations for gastrointestinal malignancies.
Breast Cancer Treatment
Focused on advanced treatment approaches for HER2-negative, hormone receptor positive breast cancer, particularly in first-line therapeutic settings.
- Advanced breast cancer management
- Hormone receptor positive disease
- Molecular pattern analysis
Specializes in comprehensive analysis of treatment efficacy and resistance patterns.
Supportive Cancer Care
Investigates preventive and therapeutic approaches for chemotherapy-induced polyneuropathy, focusing on improving patient quality of life during treatment.
- Neuropathy prevention strategies
- Alternative therapeutic approaches
- Quality of life management
Develops interventions to reduce chemotherapy-related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.